These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 24613203)

  • 1. Suppressive effect of compact bone-derived mesenchymal stem cells on chronic airway remodeling in murine model of asthma.
    Ogulur I; Gurhan G; Aksoy A; Duruksu G; Inci C; Filinte D; Kombak FE; Karaoz E; Akkoc T
    Int Immunopharmacol; 2014 May; 20(1):101-9. PubMed ID: 24613203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cells ameliorate the histopathological changes in a murine model of chronic asthma.
    Firinci F; Karaman M; Baran Y; Bagriyanik A; Ayyildiz ZA; Kiray M; Kozanoglu I; Yilmaz O; Uzuner N; Karaman O
    Int Immunopharmacol; 2011 Aug; 11(8):1120-6. PubMed ID: 21439399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic pluripotent stem cells suppress airway inflammation in murine model of acute asthma.
    Ogulur I; Gurhan G; Kombak FE; Filinte D; Barlan I; Akkoc T
    Int Immunopharmacol; 2014 Sep; 22(1):31-40. PubMed ID: 24957687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Simvastatin and Bone Marrow-Derived Mesenchymal Stem Cell Combination Therapy on Airway Remodeling in a Mouse Asthma Model.
    Mohammadian M; Sadeghipour HR; Kashani IR; Jahromi GP; Omidi A; Nejad AK; Golchoobian R; Boskabady MH
    Lung; 2016 Oct; 194(5):777-85. PubMed ID: 27161569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells suppress lung inflammation and airway remodeling in chronic asthma rat model via PI3K/Akt signaling pathway.
    Lin HY; Xu L; Xie SS; Yu F; Hu HY; Song XL; Wang CH
    Int J Clin Exp Pathol; 2015; 8(8):8958-67. PubMed ID: 26464637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal administration of mesenchymoangioblast-derived mesenchymal stem cells abrogates airway fibrosis and airway hyperresponsiveness associated with chronic allergic airways disease.
    Royce SG; Rele S; Broughton BRS; Kelly K; Samuel CS
    FASEB J; 2017 Sep; 31(9):4168-4178. PubMed ID: 28626025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mesenchymal stem cells on inhibiting airway remodeling and airway inflammation in chronic asthma.
    Ge X; Bai C; Yang J; Lou G; Li Q; Chen R
    J Cell Biochem; 2013 Jul; 114(7):1595-605. PubMed ID: 23334934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal Stromal Cell Therapy Alleviates Ovalbumin-Induced Chronic Airway Remodeling by Suppressing M2 Macrophage Polarization.
    Yu H; Zhu G; Qin Q; Wang X; Guo X; Gu W
    Inflammation; 2024 Aug; 47(4):1298-1312. PubMed ID: 38316671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model.
    Işık S; Karaman M; Adan A; Kıray M; Bağrıyanık HA; Sözmen ŞÇ; Kozanoğlu İ; Karaman Ö; Baran Y; Uzuner N
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):197-207. PubMed ID: 27380271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bone marrow-derived adult stem cells in a transgenic mouse model of allergic asthma.
    Ou-Yang HF; Han XP; Zhao F; Ti XY; Wu CG
    Respiration; 2012; 83(1):74-80. PubMed ID: 21968331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model.
    Urbanek K; De Angelis A; Spaziano G; Piegari E; Matteis M; Cappetta D; Esposito G; Russo R; Tartaglione G; De Palma R; Rossi F; D'Agostino B
    PLoS One; 2016; 11(7):e0158746. PubMed ID: 27434719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic administration of bone marrow-derived mesenchymal stromal cells reduces airway inflammation without up-regulating Tregs in experimental asthma.
    Kitoko JZ; de Castro LL; Nascimento AP; Abreu SC; Cruz FF; Arantes AC; Xisto DG; Martins MA; Morales MM; Rocco PRM; Olsen PC
    Clin Exp Allergy; 2018 Feb; 48(2):205-216. PubMed ID: 29068567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of TNF antagonism by etanercept and dexamethasone on airway epithelium and remodeling in an experimental model of asthma.
    Yilmaz O; Karaman M; Bagriyanik HA; Firinci F; Kiray M; Turkeli A; Karaman O; Yuksel H
    Int Immunopharmacol; 2013 Nov; 17(3):768-73. PubMed ID: 24063972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells and serelaxin synergistically abrogate established airway fibrosis in an experimental model of chronic allergic airways disease.
    Royce SG; Shen M; Patel KP; Huuskes BM; Ricardo SD; Samuel CS
    Stem Cell Res; 2015 Nov; 15(3):495-505. PubMed ID: 26426509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic roles of telocytes in OVA-induced acute asthma in mice.
    Ye L; Song D; Jin M; Wang X
    J Cell Mol Med; 2017 Nov; 21(11):2863-2871. PubMed ID: 28524369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of human mesenchymal stem cells on airway inflammation in allergic asthma mice and the underlying mechanism].
    Ren NN; Chen HJ; Chen QL; Eileen J; An YG; Lin Y
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2697-2702. PubMed ID: 28910960
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells.
    Ou-Yang HF; Huang Y; Hu XB; Wu CG
    Exp Biol Med (Maywood); 2011 Dec; 236(12):1461-7. PubMed ID: 22114062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic hUCMSC-derived extracellular vesicles attenuate allergic airway inflammation and airway remodeling in chronic asthma mice.
    Dong L; Wang Y; Zheng T; Pu Y; Ma Y; Qi X; Zhang W; Xue F; Shan Z; Liu J; Wang X; Mao C
    Stem Cell Res Ther; 2021 Jan; 12(1):4. PubMed ID: 33407872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratracheal transplantation of bone marrow-derived mesenchymal stem cells reduced airway inflammation and up-regulated CD4⁺CD25⁺ regulatory T cells in asthmatic mouse.
    Ge X; Bai C; Yang J; Lou G; Li Q; Chen R
    Cell Biol Int; 2013 Jul; 37(7):675-86. PubMed ID: 23483727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of low dose leukotriene receptor antagonist therapy on airway remodeling and cysteinyl leukotriene expression in a mouse asthma model.
    Muz MH; Deveci F; Bulut Y; Ilhan N; Yekeler H; Turgut T
    Exp Mol Med; 2006 Apr; 38(2):109-18. PubMed ID: 16672764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.